Kotak Healthcare Fund Factsheet

Investment Objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved.

Investment Objective

Investment Style

Portfolio

Issuer/Instrument		% to Net Assets

Equity & Equity related
Pharmaceuticals and Biotechnology		68.96
Sun Pharmaceuticals Industries Ltd.		13.21
Divi s Laboratories Ltd.		9.35
TORRENT PHARMACEUTICALS LTD.		4.65
ACUTAAS CHEMICALS LTD		4.17
Cipla Ltd.		3.26
GLAND PHARMA LIMITED		3.16
SAI LIFE SCIENCES LIMITED		2.96
LAURUS LABS LTD.		2.88
MANKIND PHARMA LTD		2.73
Marksans Pharma Ltd		2.44
ANTHEM BIOSCIENCES LTD		2.34
Ajanta Pharma Ltd.		1.97
RUBICON RESEARCH LTD		1.96
EMCURE PHARMACEUTICALS LIMITED		1.77
Aurobindo Pharma Ltd.		1.72
VIYASH SCIENTIFIC LTD.		1.71
ORCHID PHARMA LTD.		1.57
CORONA REMEDIES LIMITED		1.52
INNOVA CAPTABS LTD		1.41
JUBILANT PHARMOVA LIMITED		1.25
Zydus Lifesciences Limited		1.06
Lupin Ltd.		0.98
Pfizer Ltd.		0.89
Healthcare Services		21.06
MAX HEALTHCARE INSTITUTE LTD.		3.61
PARK MEDI WORLD LIMITED (PARK HOSPITAL)		3.17
YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD		3.12
Apollo Hospitals Enterprises Ltd.		2.97
KRISHNA INSTITUTE OF MEDICAL		2.71
Fortis Healthcare India Ltd		2.33
RAINBOW CHILDRENS MEDICARE LTD		1.11
DR.Lal Pathlabs Ltd.		1.06
Metropolis Healthcare Ltd.		0.98
Healthcare Equipment and Supplies		5.08
MOLBIO DIAGNOSTICS LIMITED		5.08
Chemicals and Petrochemicals		3.59
PRASOL CHEMICALS LIMITED		2.24
JUBILANT INGREVIA LTD		1.35
Equity & Equity related - Total		98.69
Triparty Repo		3.01
Net Current Assets/(Liabilities)		-1.70
Grand Total		100.00

Sector Allocation (%)

SIP Performance

Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000	Since Inception	1 Year
Total amount invested (₹)	3,40,000	1,20,000
Total Value as on Sep 30, 2026 (₹)	4,41,645	1,41,637
Scheme Returns (%)	18.90	35.22
Nifty Healthcare Index (TRI) Returns (%)	12.33	14.46
Alpha*	6.57	20.75
Nifty Healthcare Index (TRI) (₹)#	4,04,390	1,29,126
Nifty 50 (TRI) (₹)^	3,27,446	1,11,040
Nifty 50 (TRI) Returns (%)	-2.57	-13.60

Scheme Inception : - December 11, 2023. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. Since Inception returns are assumed to be starting from the inception date of the Scheme and calculated accordingly. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. The SIP performance details provided herein are of Regular Plan - Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of Para no 7.23 of SEBI Master Circular no. HO/24/13/11(1)2026-IMD-POD-1/I/7602/2026 dated March 20, 2026, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.

About Fund

Net Asset Value (NAV)

	Regular	Direct
Growth	Rs16.7710	Rs17.5530
IDCW	Rs16.7760	Rs17.5510

(as on September 30, 2026)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)

Fund Manager*	Mr. Abhishek Bisen & Mr. Dhananjay Tikariha
Benchmark	Nifty Healthcare Index TRI
Allotment date	December 11, 2023
AAUM	Rs805.30 crs
AUM	Rs825.14 crs
Folio count	40,639

IDCW Frequency

Trustee's Discretion

Ratios

Portfolio Turnover	27.27%
^$Beta	0.97
^$Sharpe ##	0.86
^$Standard Deviation	16.40%
^^(P/E)	51.34
^^P/BV	7.03

Source: ^$ICRA MFI Explorer, ^{^^}Bloomberg

Market Capitalisation*

Large Cap	33.44%
Mid Cap	19.62%
Small Cap	45.63%
Debt & Money Market	1.31%

*% of Net Asset

Minimum Investment Amount

Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above

Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 30 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 30 days from the date of allotment: NIL

Expense Ratio**

Regular Plan:	2.36%
Direct Plan:	0.85%

Data as on 30th September, 2026 unless otherwise specified.

Folio Count data as on 31st August 2026.

Riskometer

Fund

Benchmark : Nifty Healthcare Index TRI

This product is suitable for investors who are seeking*:

Long-term capital growth
Investment in portfolio of predominantly equity & equity related securities of companies engaged in Pharma, Healthcare & allied sectors.

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

## Risk rate assumed to be 5.28% (FBIL Overnight MIBOR rate as on 30th September 2026). **The expense ratio disclosed above represents the Base Expense Ratio (BER), including applicable statutory levies on expenses forming part of the BER, but excludes brokerage, transaction costs and related statutory levies. For Total Expense Ratio including brokerage, transaction cost and related statutory levies please refer our website: https://www.kotakmf.com/Information/TER.
^* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'
For scheme performance, please refer 'For Regular Plan' & 'For Direct Plan'